MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$47,399
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from short term loan pa...
Proceeds from private offering i...
Accounts payable - related party
Others
Negative Cash Flow Breakdown
Net loss
Payments on short term loan paya...
Prepaid expenses
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net loss
6,884,474
-
Fair value adjustment - convertible debt
1,754
-
Non-cash lease expense
85,373
-14,828
Prepaid expenses
-
-274,918
Accounts receivable
-
-32,153
Employee and director equity-based compensation
26,959
937,288
Other expenses related to extinguishment of colicense agreements
-1
2,738,282
Prepaid expenses
133,388
-
Security deposits
0
-
Customer deposits
-19,364
34,364
Accounts receivable
-2,211
-
Accounts payable
132,051
313,849
Net loss
-
-5,851,418
Accounts payable - related party
263,061
-124,706
Lease liabilities
-84,899
29,818
Accrued liabilities
185,672
337,774
Net cash (used in) operating activities
-266,556
-1,906,648
Net cash from investing activities
0
0
Proceeds from short term loan payable, other
488,198
-
Proceeds from private sales of common stock - related party
-
50,000
Payments on short term loan payable, other
341,739
-
Proceeds from private sales of common stock - other
-
100,000
Proceeds from convertible note and warrants
250,000
-
Payments of loans payable, other
-
-195,279
Payment on note payable
103,475
-
Payment of term debt
-
68,890
Proceeds from private offering issuance
100,000
-
Proceeds of loans payable, other
-
488,198
Proceeds from private offering issuance - related party
295,000
-
Net cash provided by financing activities
313,955
374,029
Increase (decrease) in cash
47,399
-1,532,619
Cash and cash equivalents at beginning of period
1,542,442
-
Cash and cash equivalents at end of period
57,222
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from short term
loan payable, other
$488,198
Proceeds from private
offering issuance -...
$295,000
Proceeds from
convertible note and...
$250,000
Proceeds from private
offering issuance
$100,000
Net cash provided by
financing activities
$313,955
Canceled cashflow
$819,243
Increase (decrease) in
cash
$47,399
Canceled cashflow
$266,556
something is missing
-$374,029
Payments on short term
loan payable, other
$341,739
Payment on note payable
$103,475
something is missing
$6,158,489
Accounts payable -
related party
$263,061
Accrued liabilities
$185,672
Accounts payable
$132,051
Non-cash lease expense
$85,373
Employee and director
equity-based compensation
$26,959
Accounts receivable
-$2,211
Fair value
adjustment - convertible...
$1,754
Net cash (used in)
operating activities
-$266,556
Canceled cashflow
$6,855,570
Net loss
$6,884,474
Prepaid expenses
$133,388
Lease liabilities
-$84,899
Customer deposits
-$19,364
Other expenses
related to...
-$1
Buy us a coffee
Zivo Bioscience, Inc. (ZIVO)
Zivo Bioscience, Inc. (ZIVO)